Retinal Vein Occlusion: Causes, Symptoms, and Treatment

The most common symptom of retinal vein occlusion is a sudden, painless change in vision in one eye. Many people notice blurry or distorted vision that develops over just a few hours or a day or two. The change typically affects only one eye, though the location and extent of the vision loss depends on which vein is blocked and how severely.

With BRVO, the vision loss may involve only a segment of the visual field, since only one branch of the retinal drainage system is affected. With CRVO, the vision loss tends to be more widespread, because the entire retina is deprived of proper drainage.

Some people with RVO notice a sudden increase in floaters, which are dark spots, threads, or cobweb-like shapes that drift across the field of vision. Floaters can occur when blood leaks into the vitreous, causing a vitreous hemorrhage. In some cases, a sudden surge of new floaters may be the first visible sign of an occlusion that had been developing silently.

Most cases of retinal vein occlusion are completely painless. However, if a severe CRVO leads to neovascular glaucoma, the eye may become painful, red, and visibly irritated. These symptoms signal a serious complication that requires urgent attention.

Any sudden vision change in one eye, whether blurry vision, a flood of new floaters, or a shadow across any part of your visual field, should be treated as a medical emergency. Please seek evaluation right away rather than waiting.

Anti-VEGF treatment typically begins with a series of monthly injections during an initial loading phase. This concentrated course of treatment is designed to reduce macular swelling and stabilize vision as quickly as possible. Once the retina has shown a positive response, we may gradually extend the interval between injections based on how your eye continues to do.

Intravitreal injections are performed in our office. The eye is numbed with anesthetic drops, and the injection itself takes only a few seconds. Most patients feel mild pressure during the procedure but report little to no pain. Some patients notice temporary floaters immediately afterward, which typically resolve on their own within a short time.

How much vision recovers depends on several factors: the type of occlusion, how promptly treatment begins, and how much retinal damage occurred before care started. Many patients with BRVO experience meaningful vision improvement with consistent anti-VEGF treatment. Patients with CRVO may have more variable results, particularly when significant ischemia (oxygen deprivation to the retina) is present before treatment begins.

It is important to have realistic expectations going into treatment. Some patients recover much of their lost vision. Others experience partial improvement, or find that treatment stabilizes their vision and prevents further decline rather than reversing damage that has already occurred. Every case is different, and staying committed to your care plan gives you the best possible chance at a good outcome.

Even after vision has stabilized, RVO requires ongoing monitoring. Macular edema can return, and new complications can develop over time. Regular visits allow us to detect any changes early and respond before they affect your vision. Some patients require continued injections for many months or years, while others are gradually able to taper off treatment once the retina has stabilized.

It is uncommon for RVO to affect both eyes simultaneously. However, having an occlusion in one eye does raise the chance of eventually developing one in the other, especially if the underlying systemic risk factors such as high blood pressure or diabetes remain poorly controlled. This is one reason why we monitor both eyes at every follow-up visit, even when only one eye has been diagnosed. Keeping systemic risk factors well managed is the most effective way to protect the fellow eye.

There is no single answer because every patient's retina responds differently. Some patients complete a loading phase and then require only periodic maintenance injections to keep fluid from returning. Others need ongoing treatment for a year or longer. Newer agents like faricimab (Vabysmo) are designed to allow extended intervals between doses in suitable patients, which can reduce the overall treatment burden over time. Your retina specialist will continuously adjust your schedule based on how your eye responds at each visit, rather than following a fixed predetermined timetable.

RVO and stroke share many of the same underlying risk factors, including high blood pressure, diabetes, and elevated cholesterol. While a retinal vein occlusion is not the same as a stroke, it is a vascular event in the eye and can serve as an early signal that your cardiovascular health deserves closer attention. We recommend that patients newly diagnosed with RVO be evaluated by their primary care physician to assess their full cardiovascular risk profile. Identifying and treating these systemic conditions may help reduce the risk of more serious vascular events in other parts of the body.

Treatment should begin as soon as possible after diagnosis, ideally within days of symptom onset. The longer macular edema goes untreated, the more likely it is that permanent structural changes will occur in the retina's central layers. If you have recently been diagnosed with RVO or are currently experiencing symptoms, please do not delay in seeking care. Our practice evaluates urgent and emergency referrals, and we work to see new patients with active vision concerns as quickly as possible.

Recovery depends heavily on the type and severity of the occlusion, how promptly treatment was initiated, and how much of the central retina was damaged before care began. Patients with BRVO generally have better visual recovery than those with CRVO, and those who are treated early tend to do better than those who wait. Some patients do regain most of their lost vision. Others may have lasting changes, and treatment may aim to stabilize rather than fully restore sight. What we can say with confidence is that prompt treatment and consistent follow-up give you the best possible chance of recovering and protecting the vision you have.

While there is no way to eliminate the risk entirely, managing the underlying conditions that contributed to the first occlusion can meaningfully lower the chance of recurrence. This means working closely with your primary care physician to keep blood pressure, blood sugar, and cholesterol within healthy ranges. Maintaining a heart-healthy lifestyle, avoiding smoking, staying physically active, and remaining consistent with your eye care appointments all contribute to long-term protection. In younger patients or those with blood clotting abnormalities, additional management strategies may be recommended by your care team.